StockData
Lakefront Biotherapeutics NV logo

Lakefront Biotherapeutics NV (LKFT) shareholders

LKFTNasdaqPharmaceutical PreparationsAlso trades as GLPGF
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Score 7/30
$34.39−0.40 (-1.15%)

Close on Nov 17, 2026Market cap $2.27BP/E 6.4Yield –

Ownership

Institutional holdings as of Jun 30, 2026, from 13F filings

Held by institutions
32M
Shares held, 13F filers
Institutional holders
77
9 new, 21 sold out
Net institutional buying
1M
In Q2 2026
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only

Shares held by institutions

Holders of more than 5%

Latest Schedule 13D (active) or 13G (passive) filed by each holder

HolderShares% of classFilingAs of
Gilead Sciences, Inc.
Joint filing with Gilead Therapeutics A1 Unlimited Company (29.90%)
20,981,01029.90%13D (active) amendmentJan 7, 2025
Oleg Nodelman
Joint filing with EcoR1 Capital, LLC (13.22%), EcoR1 Capital Fund Qualified, L.P. (12.43%)
8,714,52213.22%13D (active) amendmentJul 24, 2025
EcoR1 Capital, LLC
Joint filing with Oleg Nodelman (11.84%), EcoR1 Capital Fund Qualified, L.P. (11.14%)
7,803,20211.84%13D (active) amendmentMay 15, 2025
Kevin Tang
Joint filing with Tang Capital Management, LLC (8.40%), Tang Capital Partners, LP (5.00%)
5,559,6748.40%13G (passive)Oct 27, 2025
Eli Samaha
Joint filing with Madison Avenue International LP (5.50%), Madison Avenue Partners, LP (5.50%) and 3 more
3,606,2035.50%13G (passive)Jun 15, 2026

Top institutional holders

13F holdings as of Jun 30, 2026

HolderShares% of LKFTValueChange% of portfolio
Gilead Sciences, Inc.16,707,477–$500.16M–30.34%
Tang Capital Management LLC3,785,991–$113.50M–5.16%
Madison Avenue Partners, LP3,447,807–$103.37M+982,6284.45%
Prosight Management, LP2,043,344–$61.26M+493,34410.56%
EcoR1 Capital, LLC1,667,119–$49.98M–2.43%
Ameriprise Financial Inc1,272,249–$38.14M−152,4250.01%
DME Capital Management, LP482,746–$14.47M–0.37%
Renaissance Technologies LLC407,800–$12.23M+92,4000.02%
BlackRock, Inc.338,152–$10.14M+26,0460.00%
Point72 Asset Management, L.P.269,814–$8.09M−62,3110.01%
D. E. Shaw & Co., Inc.197,844–$5.93M−17,8740.00%
Millennium Management LLC181,090–$5.43M+73,1780.00%
UBS Group AG168,148–$5.04M−7,1410.00%
Susquehanna International Group, Llp151,886–$4.55M+138,4990.00%
DAFNA Capital Management LLC130,175–$3.90M–0.74%
Citadel Advisors LLC88,343–$2.65M−36,0850.00%
Two Sigma Investments, LP81,749–$2.45M+55,8890.00%
Norges Bank76,879–$2.30MNew0.00%
Alps Advisors Inc65,523–$1.96M+11,8620.01%
Goldman Sachs Group Inc56,581–$1.70M+11,2100.00%

Institutional buying and selling by quarter

Positions opened, added to, reduced and closed by 13F filers

QuarterHoldersShares heldNew / addedReduced / closedShares boughtShares sold
Q2 20267732M9 / 2628 / 212M1M
Q1 20269031M16 / 3328 / 151M1M
Q4 20259131M16 / 2833 / 161M1M
Q3 20259231M18 / 3129 / 113M3M
Q2 20258532M21 / 2524 / 185M4M
Q1 20258331M17 / 2230 / 153M3M
Q4 20248131M12 / 2424 / 1019M2M
Q3 20247914M11 / 2524 / 162M8M
Q2 20248520M12 / 3818 / 91M2M
Q1 20248221M9 / 2728 / 142M1M
Q4 20238820M20 / 3617 / 52M1M
Q3 20237320M6 / 3220 / 82M2M

Top mutual fund and ETF holders

Latest monthly portfolio reports (Form N-PORT)

17 funds held LKFT in Q2 2026, 22% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.

FundShares% of LKFTValue% of fundAs of
Columbia Overseas Value Fund746,801–$21.17M0.31%May 31, 2026
iShares Biotechnology ETF292,580–$8.77M0.10%Jun 30, 2026
Columbia Variable Portfolio - Overseas Core Fund280,317–$8.40M0.22%Jun 30, 2026
Columbia Overseas Core Fund90,697–$2.57M0.26%May 31, 2026
ALPS Medical Breakthroughs ETF67,945–$1.93M1.19%May 31, 2026
Avantis International Equity ETF30,449–$863.23K0.01%May 31, 2026
International Value Fund28,283–$801.82K0.16%May 31, 2026
ActivePassive International Equity ETF18,273–$518.04K0.05%May 31, 2026
Steward Values Enhanced International Fund16,569–$450.84K0.13%Jul 31, 2026
Fidelity Nasdaq Composite Index Fund10,150–$287.75K0.00%May 31, 2026
Avantis International Small Cap Equity ETF6,762–$191.70K0.06%May 31, 2026
Avantis International Equity Fund2,478–$70.25K0.01%May 31, 2026
Invesco Nasdaq Biotechnology ETF794–$22.51K0.03%May 31, 2026
ProShares Ultra Nasdaq Biotechnology548–$15.54K0.02%May 31, 2026
Blackstone Alternative Multi-Strategy Fund100–$3.00K0.00%Jun 30, 2026

Short interest

Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)

Short % of shares outstanding
–
1M shares short
Days to cover
6.0
At 0M shares a day
Change since last report
-8.2%
From 1M shares
Short volume, 20 days
54.7%
Of volume reported to FINRA

Shares sold short, last 6 months

Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Lakefront Biotherapeutics's stock actually held short. Settlement fails (shares not delivered on time) peaked at 7,727 shares on Oct 9, 2026 over the last 90 days.

See a number that looks wrong?